Euronext N.V. : Back on key levels based on weekly price data
Entry price | Target | Stop-loss | Potential |
---|
€85.5 |
€100 |
€78 |
+16.96% |
---|
Euronext N.V. shares are sitting close to an important technical support area around 83 EUR based on weekly price data. Against this backdrop, investors can use this good timing for new long positions.
Strengths● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● The group's activity appears highly profitable thanks to its outperforming net margins.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
Surperformance is Buy on EURONEXT N.V. since 11/10/2023
.